Is it safe to use propofol in the emergency department? a randomized controlled trial to compare propofol and midazolam

被引:13
|
作者
Hisamuddin N. [1 ,3 ]
Rahman N.A. [1 ,3 ]
Hashim A. [2 ]
机构
[1] Consultant and Head of Emergency Medicine, PPSP, USM, Kubang Kerian
[2] Department of Emergency and Trauma, Queen Elizabeth Hospital, Kota Kinabalu, Sabah
[3] Department of Emergency Medicine, School of Medical Sciences, USM
关键词
Emergency department; Midazolam; Procedural sedation analgesia; Propofol;
D O I
10.1007/s12245-010-0162-3
中图分类号
学科分类号
摘要
Background This study examined the safety and effectiveness of the procedural sedation analgesia (PSA) technique carried out in the emergency department (ED) of a university hospital over a period of 1 year. The research was done to compare the effectiveness and efficacy of moderate sedation of fentanyl combined with either mid-azolam or propofol for any brief, intense procedure in the ED setting. Aims The objectives were to observe the occurrence of adverse events in subjects undergoing PSA for intense and painful procedures in the emergency department and to implement the use of capnography as a method of monitoring the patients when they were under PSA. Methods Forty patients were selected for this study. They were randomly divided into two equal groups using the computer-generated random permuted blocks of four patients. Twenty patients were grouped together as group A and the remaining 20 patients as group B. Drugs used were single blinded to prevent any bias. Drug A was propofol and fentanyl, while drug B was midazolam and fentanyl. The procedures involved included orthopedic manipulation such as reduction of fractures, reduction of dislocated joints, abscess drainage, wound debridement, laceration wound repair and cardioversion. All of the subjects were monitored for their vital signs and end tidal carbon dioxide level every 10 min till the PSA was completed. The duration of stay in the ED was documented when the subjects had completed the procedure and were released from the department. Result Of the study population, 75.6% were males. The mean age was 37.8 years (95% CI 33.2, 39.8). None of the patients developed any major complications while under PSA. The vital signs pre-, intra- and post-procedure were not significantly different in either the propofol or miz-adolam groups (p value >0.05). Conclusion This study had proven that there was no difference in adverse event occurrence between the studied drugs during PSA. Propofol can be recommended for use in PSA if the operator is well trained and familiar with the drug. © Springer-Verlag London Ltd 2010.
引用
收藏
页码:105 / 113
页数:8
相关论文
共 50 条
  • [31] A review of the use of propofol for procedural sedation in the emergency department
    Symington, L
    Thakore, S
    EMERGENCY MEDICINE JOURNAL, 2006, 23 (02) : 89 - 93
  • [32] Randomized, Double-Blinded, Clinical Trial of Propofol, 1:1 Propofol/Ketamine, and 4:1 Propofol/Ketamine for Deep Procedural Sedation in the Emergency Department
    Miner, James R.
    Moore, Johanna C.
    Austad, Erin J.
    Plummer, David
    Hubbard, Laura
    Gray, Richard O.
    ANNALS OF EMERGENCY MEDICINE, 2015, 65 (05) : 479 - 488
  • [33] The Utility of High-Flow Oxygen During Emergency Department Procedural Sedation and Analgesia With Propofol: A Randomized, Controlled Trial
    Deitch, Kenneth
    Chudnofsky, Carl R.
    Dominici, Paul
    Latta, Daniel
    Salamanca, Yidy
    ANNALS OF EMERGENCY MEDICINE, 2011, 58 (04) : 360 - 364
  • [34] Ketamine With and Without Midazolam for Emergency Department Sedation in Adults: A Randomized Controlled Trial
    Sener, Serkan
    Eken, Cenker
    Schultz, Carl H.
    Serinken, Mustafa
    Ozsarac, Murat
    ANNALS OF EMERGENCY MEDICINE, 2011, 57 (02) : 109 - 114
  • [35] Propofol vs midazolam for ICU sedation - A Canadian multicenter randomized trial
    Hall, RI
    Sandham, D
    Cardinal, P
    Tweeddale, M
    Moher, D
    Wang, XH
    Anis, AH
    CHEST, 2001, 119 (04) : 1151 - 1159
  • [36] A comparison of the effects of midazolam, propofol and dexmedetomidine on the antioxidant system: A randomized trial
    Han, Chao
    Ding, Weiliang
    Jiang, Wenjie
    Chen, Yu
    Hang, Dongyuan
    Gu, Daming
    Jiang, Guojun
    Tan, Yongfei
    Ge, Zhijun
    Ma, Tieliang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (06) : 2293 - 2298
  • [37] A randomized trial of propofol and midazolam for sedation in upper GI-endoscopy.
    Jung, M
    Hofmann, C
    Brackertz, A
    GASTROENTEROLOGY, 1998, 114 (04) : A20 - A21
  • [38] Comparison of Midazolam Plus Propofol With Propofol Alone for Upper Endoscopy: A Prospective, Single Blind, Randomized Clinical Trial
    Lee, Jeung Eun
    Lee, Sang Kil
    Chung, Hyunsoo
    Park, Jun Chul
    Shin, Sung Kwan
    Lee, Yong Chan
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB222 - AB222
  • [39] Effects of propofol, dexmedetomidine, and midazolam on postoperative cognitive dysfunction in elderly patients: a randomized controlled preliminary trial
    Li Wei-Xia
    Luo Ru-Yi
    Chen Chao
    Li Xiang
    Ao Jing-Sheng
    Liu Yue
    Yin Yi-Qing
    中华医学杂志(英文版), 2019, 132 (04) : 437 - 445
  • [40] Comparison of propofol with midazolam in endoscopic submucosal dissection for esophageal squamous cell carcinoma: a randomized controlled trial
    Masaki Ominami
    Yasuaki Nagami
    Masatsugu Shiba
    Kazunari Tominaga
    Taishi Sakai
    Hirotsugu Maruyama
    Kunihiro Kato
    Hiroaki Minamino
    Shusei Fukunaga
    Fumio Tanaka
    Satoshi Sugimori
    Noriko Kamata
    Hirohisa Machida
    Hirokazu Yamagami
    Tetsuya Tanigawa
    Toshio Watanabe
    Yasuhiro Fujiwara
    Tetsuo Arakawa
    Journal of Gastroenterology, 2018, 53 : 397 - 406